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Summary. Pro-inflammatory cytokines, such as
interleukin-1ß (IL-1ß) and tumor necrosis factor-α
(TNF-α) play a key role in the pathogenesis of
Osteoarthritis (OA). The aim of this study was to
investigate the potential anti-inflammatory properties of
the growth factors IGF-I and/or TGF-ß1 on IL-1ß
signalling pathways and their effect on the chondrogenic
potential of dedifferentiated human articular
chondrocytes in vitro.
Serum-starved human articular chondrocytes were
treated with IL-1ß to induce dedifferentiation and further
treated with IGF-I and/or TGF-ß1 at various
concentrations. The effects of growth factors were
evaluated both in monolayer and high-density cultures.
Incubation with the cytokine IL-1ß resulted in rapid
dedifferentiation of the cells; they lost their chondrocyte-
like phenotype while down-regulating the expression of
collagen type II, integrin, extracellular regulated kinase
(Erk 1/2) and the chondrogenic transcription factor
Sox9. Co-treatment with IGF-I and/or TGF-ß1
stimulated the cells to redifferentiate, increasing the
expression of the above-mentioned cartilage-specific
proteins. These events correlated with down-regulation
of cyclooxygenase-2 (COX-2) and matrix metallo-
proteinase-13 (MMP-13). Furthermore, in high-density
cultures, we observed evidence for new cartilage
formation after co-treatment with these growth factors.
We further detected that all examined proteins were
more strongly expressed during combination treatment. 
These results indicate that IGF-I and TGF-ß1 exert
additive anabolic effects on chondrocytes and may
stabilize the chondrogenic potential. The additive action
of these growth factors on chondrocytes may find
practical applications in the fields of OA and cartilage
tissue engineering.
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Introduction
In modern societies, we observe an increasing
number of people suffering from degenerative joint
diseases, often leading to major impediments in
everyday life for these patients and high costs for the
welfare systems. Degenerative influences trigger
pathologic changes to chondrocyte function and
phenotype during Osteoarthritis (OA). Pro-inflammatory
cytokines released from activated synoviocytes and
articular cartilage cells promote degradation of
extracellular matrix compounds (Feldmann et al., 1996;
Fernandes et al., 2002). Many investigators have
demonstrated that cytokines, like IL-1ß and TNF-α, are
produced in high amounts during OA in the cartilage and
in turn stimulate the synthesis of other pro-inflammatory
catabolic factors and mediators of degradation and
inflammation, such as MMPs (Ryu et al., 1984; Robbins
et al., 2000; Fernandes et al., 2002) and COX-2 (Largo
et al., 2003). However, IL-1ß may also contribute to the
depletion of cartilage matrix by decreasing the synthesis
of cartilage-specific proteoglycans and collagen type II
(Studer et al., 1999; Goldring, 2000; Robbins et al.,
2000). Apoptosis is another contributing factor to the
loss of articular cartilage in OA and it is known that
apoptosis increases the cell loss observed in aging and
OA cartilage (Goldring, 2000).
Recently, the Autologous Chondrocyte Implantation
(ACI) has been proposed as the gold standard for the
repair of articular cartilage lesions (Brittberg et al.,
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1994). However, although results obtained until now are
quite encouraging (Peterson et al., 2002), the main
limitation for successful ACI is often the poor
integration of the newly formed cartilage tissue. This is
mainly due to the expansion phase in monolayer culture
where chondrocytes gradually lose their specific
phenotype, dedifferentiate into fibroblast-like cells and
thus lose their chondrogenic potential (von der Mark et
al., 1977; Quarto et al., 1990; Shakibaei, 1995;
Shakibaei et al., 1997). These dedifferentiating processes
lead to chondrocytes that are incapable of initiating
cartilage defect repair, resulting in fibrous cartilage
tissue. However, the expansion phase is necessary, since
primary chondrocyte yields from biopsies are low and do
not suffice to refill cartilage defects immediately. For
this reason, new and improved in vitro strategies need to
be investigated.
It has been observed that after monolayer expansion
up to the fourth passage, chondrocytes are able to
redifferentiate spontaneously in three dimensional
surroundings, such as in alginate or high-density culture
(Schulze et al., 2000; Schulze-Tanzil et al., 2002, 2004).
Growth factors are known to exert anabolic effects on
chondrocytes in vivo and in vitro by influencing
chondrocyte proliferation, differentiation, growth and
survival (Mandl et al., 2004). Especially, members of the
TGF-superfamily, such as Transforming growth factor-
ß1 (TGF-ß1), have more and more come into focus as
potential candidates for enhancing cartilage repair. TGF-
ß1 is known to be expressed in normal articular
cartilage, where it is able to augment cell proliferation.
Furthermore, it influences and enhances the production
of cartilage matrix-specific proteins (Denker et al.,
1995). Insulin-like growth factor-I (IGF-I) has been
shown to augment the synthesis of cartilage-specific
matrix proteins in vivo and in vitro (Yaeger et al., 1997;
Mi et al., 2000; Shakibaei et al., 2006). Furthermore,
IGF-I, as well as TGF-ß1, strongly promote
chondrogenesis in progenitor cells such as mesenchymal
stem cells in vitro (Fukumoto et al., 2003; Longobardi et
al., 2006).
Because of the well established and potent anabolic
effects of these growth factors in cartilage and because
only limited investigations have been done in cartilage
metabolism and combined growth factor therapy, in this
study we wanted to examine the influence of IGF-I and
TGF-ß1 on restoring the chondrogenic potential of
dedifferentiated chondrocytes from monolayer culture.
Furthermore, this study suggests the usefulness of
cytokine inhibition or inhibition of cytokine downstream
factors by growth factors during the treatment of OA,
thereby improving chondrocyte cultivation in vitro and
thus the success of ACI. 
Materials and methods
Antibodies
Antibodies against collagen type II, cartilage-
specific proteoglycan and ß1-integrin, as well as
secondary antibodies, were purchased from Chemicon
International (Temecula, CA, USA). Antibodies to active
caspase-3 and MMP-13 were from R&D Systems, Inc.,
(Wiesbaden, Germany). Sox9 antibody was purchased
from Acris Antibodies GmbH (Hiddenhausen,
Germany), Phospho-p42/p44 Erk1/2 from R&D, COX-2
antibody from Cayman (Michigan, USA) and anti-ß-
actin antibody from Sigma (Munich, Germany). 
Growth medium and cytokines
The applied growth medium was obtained from
Seromed (Munich, Germany). It consists of Ham’s F-12
and Dulbecco’s modified eagles medium containing 10%
fetal calf serum (FCS), 25 µg/ml ascorbic acid, 50 IU/ml
streptomycin and penicillin, 2.5 µg/ml amphotericin B,
1% essential amino acids and 1% L-glutamine. Alginate
and trypsin/EDTA were purchased from Sigma (Munich,
Germany), IL-1ß from Strathman Biotech GmbH
(Hannover, Germany) and IGF-I and TGF-ß1 from
Pepro-Tech (London, UK).
Chondrocyte isolation and culture conditions
Primary chondrocytes were isolated from articular
cartilage obtained during joint replacement surgery of
femoral head fractures as described earlier (Shakibaei et
al., 1999). Cartilage samples were derived from three
middle-aged patients and used for the investigations.
After isolation, the cells were re-suspended in growth
medium and cultured in a three dimensional alginate
system as previously described (Shakibaei and De
Souza, 1997). Briefly, one million cells were re-
suspended in 1 ml of alginate. This solution was dripped
into a calcium-chlorid solution were it polymerised to
beads. After washing with buffer, these beads were
cultured in whole cell culture medium containing 10%
FCS. After a few days of culturing, the chondrocytes
migrated from the alginate and adhered to petri dishes in
monolayers (Schulze-Tanzil et al., 2004). Studies from
our laboratory have shown that alginate functions as a
selective filter station separating vital from non-vital
chondrocytes and fibroblasts (Schulze-Tanzil et al.,
2002, 2004). These cells were used for our experimental
design. For all the experiments described these
emigrated chondrocytes were passaged only twice to
circumvent dedifferentiation. Gradually the culture
medium was converted into serum-starved medium
containing only 0.5% FCS. 
Experimental design
The experiments performed in this study were
performed on chondrocytes isolated from three
individual donors (n=3) and specifically designed to
mimic cellular events that occur in the clinical condition
of OA: to induce chondrocyte dedifferentiation
processes in monolayer cultures we adopted a model
which stimulates chondrocytes with the pro-
inflammatory cytokine IL-1ß (10 ng/ml). During
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monolayer expansion chondrocytes were cultured in
whole cell culture medium containing 10% FCS. Before
starting the experiments described here, chondrocytes
were washed three times with serum-starved medium
(containing only 0.5% FCS) and further incubated for 30
minutes with serum-starved medium before starting the
IL-1ß treatment. Serum-starved chondrocytes were
stimulated with (10 ng/ml) IL-1ß alone for 24 hours
before being co-treated with 10 ng/ml IL-1ß and IGF-I
(100 ng/ml) or TGF-ß1 (100 ng/ml) or the combination
of both growth factors at various concentrations (10, 100
ng/ml) for an additional 24 or 48 hours. Growth factor
concentrations used in the presented experiments were
determined in previous studies from our own laboratory
through dose dependent experiments on human articular
chondrocytes. Furthermore, in a second approach,
monolayer cultured chondrocytes, treated as presented
above, were transferred to high-density cultures and
cultured under identical conditions with serum-starved
medium, in order to examine the effects of IGF-I and/or
TGF-ß1 on chondrocyte redifferentiation potential in a
three dimensional environment. Three dimensional high-
density culture was performed as previously described
by Shakibaei et al. (1993). Briefly, one million cells
were pipetted onto a nitrocellulose filter resting on a
steel net bridge. Cell culture medium reached the filter
medium interface and cells were nurtured through
diffusion. After one day in culture cells aggregated and
formed a pellet on the filter (Shakibaei et al., 1993,
1995; Shakibaei and Mohamed-Ali, 1994). After seven
days of culture, cultures were prepared for further
investigations. 
Western blot analysis
Western blot analysis were performed three times for
each donor as previously described (Shakibaei et al.,
2006). After adjusting the equal amounts of total
proteins they were separated by SDS-PAGE under
reducing conditions and transferred onto nitrocellulose
membranes. Specific binding was quantified by
densitometry using “quantity one” (Bio-Rad
Laboratories Inc. CA, USA).
Transmission electron microscopy
Cells were fixed in Karnovsky-fixative for 30
minutes and post-fixed in a 1% OsO4 solution.
Chondrocytes were dehydrated in an ascending alcohol
series before they were embedded in Epon, and cut on a
Reichert Ultracut. 2% uranyl acetate/lead citrate was
used for contrasting these ultrathin sections, as
previously described (Shakibaei et al., 1995; Shakibaei,
1998).
Statistical analysis
Results obtained in this study are expressed as the
means ± S.D. of a representative experiment performed
in triplicate. The means were compared using Student’s




After a few days in a three dimensional alginate
culture cells started to migrate from the alginate and
adhered at the bottom of the culture flask, reaching
confluence three days later. Emigrated chondrocytes
exhibited a typical chondrogenic round shape and
proliferated rapidly (data not shown). 
Growth factors (IGF-I and TGF-ß1) inhibit IL-1ß-induced
degenerative features and apoptosis in emigrated
chondrocytes in monolayer culture
Chondrocytes in control monolayer cultures showed
a typical flattened shape with small cytoplasmic
processes, a large mostly euchromatic nucleus with
nucleoli and a well structured cytoplasm (Fig. 1A).
Treatment of chondrocyte cultures with 10 ng/ml IL-1ß
for 24 hours led to degenerative changes, such as
multiple vacuoles, swelling of rough ER, clustering of
swollen mitochondria and degeneration of other cell
organelles (Fig. 1B). After longer incubation periods (48
and 72 hours) more severe features of cellular
degeneration were seen in response to IL-1ß treatment.
These included areas of condensed heterochromatin in
the cell nuclei and multiple and autophagic cytoplasmic
vacuoles. The flattened monolayer chondrocytes became
more and more rounded, lost their microvilli-like
processes and became apoptotic (Fig. 1C-D).
Chondrocytes that were pre-treated with IL-1ß (24
hours) and then co-treated with IL-1ß and IGF-I (100
ng/ml) or TGF-ß1 (100 ng/ml) for a aditional 24 and 48
hours did not only show less severe cellular degeneration
on the ultrastructural level (Fig. 1E-J), but further, in the
presence of growth factors, the morphological
degenerative features and mitochondrial swelling of the
chondrocytes nearly disappeared (Fig. 1F,G,I,J).
Combination treatment with both growth factors (IGF-I
and TGF-ß1; each 10 ng/ml) clearly showed a time-
dependent decrease in the morphological degenerative
features, in mitochondrial swelling and apoptosis of the
chondrocytes, indicating a potential synergism (Fig. 1K-
M). 
Down-regulation of collagen type II and ß1-integrin-
expression through IL-1ß on emigrated chondrocytes is
blocked and revoked by growth factors
Chondrocytes, stimulated with IL-1ß alone showed
down-regulation of the synthesis of collagen type II and
ß1-integrin in a time-dependent manner (Figs. 2, 3, I-II-
III). Co-treatment of chondrocytes with IL-1ß and IGF-I
or TGF-ß1 resulted not only in an inhibition of cytokine-
induced effects on collagen type II- and ß1-integrin-
expression, but also, in the presence of growth factors,
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Fig. 1. IGF-I and TGF-ß1 inhibit IL-1ß-induced degenerative features and apoptosis in emigrated chondrocytes in monolayer culture. Chondrocytes,
treated with IL-1ß for 24 hours (B), 48 hours (C) and 72 hours (D) exhibited characteristic features of degeneration. Chondrocytes that were pre-treated
with IL-1ß for 24 hours (E, H, K) and then co-treated with IL-1ß and IGF-I for 24 hours (F) or 48 hours (G) or TGF-ß1 for 24 hours (I) or 48 hours (J) or
both in combination for 24 hours (L) or 48 hours (M) showed less severe cell degeneration. In control cultures no ultrastructural changes were observed
(A). x 4000; Bar: 1µM.
collagen type II- and ß1-integrin-production augmented
significantly, reaching amounts of healthy, primary
chondrocytes (Figs. 2, 3, I-II). Treatment of
chondrocytes with both growth factors in combination
resulted in a markedly enhanced stimulation of collagen
type II- and ß1-integrin-expression in comparison with
single growth factor treatment (Figs. 2, 3 III).
Densitometric analysis of these results (Figs. 2, 3, I-II-
III) showed that collagen type II- and ß1-integrin-
expression increased in growth factor-treated
chondrocytes compared to IL-1ß-treated chondrocytes.
Clearly, the combination of IGF-I and TGF-ß1 showed
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Fig. 2. IL-1ß-induced down-regulation of collagen type II-expression on
emigrated chondrocytes is blocked by growth factors. Expression of
collagen type II was evaluated by western blot analysis. Monolayer
chondrocytes were stimulated for 24 hours with IL-1ß followed by co-
treatment of either IGF-I, TGF-ß1 or a combination of both for another 48
hours. Stimulation of chondrocytes with IL-1ß resulted in down-regulation
of collagen type II  in a time dependent manner. Co-treatment of
chondrocytes with IL-1ß and IGF-I or TGF-ß1 inhibited the cytokine-
induced effects on collagen type II-expression, which was even stronger
combining both growth factors. 
an additive effect on the expression of the above
mentioned proteins. Co-treatment with IGF-I (10 ng/ml)
and increased concentration of TGF-ß1 (100 ng/ml)
seemed to result in steady state ß1-integrin-expression.
Synthesis of the house-keeping protein ß-actin remained
unaffected (Figs. 2, 3, I-II-III).
Growth factors suppress IL-1ß-induced inhibition of Erk
1/2 and Sox9 in emigrated chondrocytes
Chondrocytes stimulated with IL-1ß alone showed
down-regulation of the phosphorylated Erk 1/2 (42 kDa-
band more than 44 kDa-band) in a time-dependent
manner (Fig. 4, I-II-III). Co-treatment of chondrocytes
with IL-1ß and IGF-I or TGF-ß1 resulted in an inhibition
of IL-1ß-induced effects on Erk 1/2-phosphorylation
(Fig. 4, I-II). Combined treatment of chondrocytes with
both growth factors resulted in a markedly stronger
stimulation on the Erk 1/2-phosphorylation than each
growth factor separately (Fig. 4, III). Erk 1 (44 kD) and
Erk 2 (42 kD) show 90% sequence identity in mammals.
Erk 2 is generally higher expressed in mammals.
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Fig. 3. IL-1ß-induced down-regulation of ß1-integrin-expression on
emigrated chondrocytes is blocked by growth factors. Expression of ß1-
integrin was evaluated by western blot analysis. Monolayer
chondrocytes were stimulated for 24 hours with IL-1ß‚ followed by co-
treatment of either IGF-I, TGF-ß1 or a combination of both for another
48 hours. Stimulation of chondrocytes with IL-1ß resulted in down-
regulation of ß1-integrin in a time dependent manner. Co-treatment of
chondrocytes with IL-1ß‚ and IGF-I or TGF-ß1 inhibited the cytokine-
induced effects on ß1-integrin-expression, which was even stronger
combining both growth factors. Co-treatment with an increased
concentration of TGF-ß1 (100 ng/ml) seemed to result in steady state
expression of ß1-integrin. Expression of the house-keeping protein ß-
actin remained unaffected.
Therefore, as observed, the influence of combination
treatment of IGF-I and TGF-ß1 was better visibly in the
42 kDa-band. This points to an additive action of the
combination treatment of IGF-I and TGF-ß1.
Densitometric analysis of the above presented results
(Fig. 4, I-II-III) showed that Erk 1/2-phosphorylation
increased in growth factor-treated chondrocytes
compared to IL-1ß-treated chondrocytes. The highest
levels of Erk 1/2-phosphorylation were identified under
combined treatment with both growth factors. Synthesis
of the house-keeping protein ß-actin remained
unaffected (Fig. 4, I-II-III).
Chondrocytes stimulated with IL-1ß alone showed
down-regulation of the synthesis of Sox9 in a time-
dependent manner (Fig. 5, I-II-III). Co-treatment of
chondrocytes with IL-1ß and IGF-I or TGF-ß1 resulted
in an inhibition of cytokine-induced effects on Sox9
(Fig. 5, I-II). Combined treatment of emigrated
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Fig. 4. IL-1ß-induced down-regulation of Erk 1/2-phosphorylation on
emigrated chondrocytes is prevented by growth factors. Monolayer
chondrocytes were stimulated for 24 hours with IL-1ß followed by co-
treatment of either IGF-I, TGF-ß1 or a combination of both for another
48 hours. Results of western blot analysis revealed IL-1ß-induced down-
regulation of Erk 1/2 which was inhibited by co-treatment with IGF-I
and/or TGF-ß1. The combination of IGF-I and TGF-ß1 showed an
additive effect on the expression of the protein. 
chondrocytes with both growth factors induced more
expression of the Sox9 protein than each growth factor
separately (Fig. 5, III). Densitometric analysis of a
typical western blot experiment performed in triplicate
(Fig. 5, I-II-III) showed that Sox9-expression increased
in growth factor-treated chondrocytes compared to IL-
1ß-treated chondrocytes. The combination of the two
growth factors stimulated the highest Sox9-synthesis,
whereas in the presence of increased TGF-ß1-
concentration (100 ng/ml) Sox9-expression seemed to
reach a steady state. Synthesis of the house-keeping
protein ß-actin remained unaffected (Fig. 5, I-II-III).
Up-regulation of pro-inflammatory enzymes by IL-1ß on
emigrated chondrocytes is inhibited by growth factors
Chondrocytes stimulated with IL-1ß alone showed
up-regulation of the synthesis of COX-2 and MMP-13 in
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Fig. 5. IL-1ß-induced down-regulation of the chondrogenic transcription
factor Sox9 on emigrated chondrocytes is prevented by growth factors.
Monolayer chondrocytes were stimulated for 24 hours with IL-1ß
followed by co-treatment of either IGF-I, TGF-ß1 or a combination of
both for another 48 hours. Results of western blot analysis revealed IL-
1ß-induced down-regulation of Sox9 which was inhibited by co-
treatment with IGF-I and/or TGF-ß1. The combination of IGF-I and TGF-
ß1 showed an additive effect on the expression of the above protein.
Co-treatment with an increased concentration of TGF-ß1 (100 ng/ml)
seemed to result in steady state Sox9-expression (Fig. 5 III). Synthesis
of the house-keeping protein ß-actin remained unaffected.
a time-dependent manner (Figs. 6, 7). Co-treatment of
chondrocytes with IL-1ß and IGF-I or TGF-ß1 resulted
in an inhibition of cytokine-induced up-regulation of
COX-2 and MMP-13 (Figs. 6, 7, I-II). Treatment of
chondrocytes with both growth factors resulted in a
stronger inhibition of COX-2- and MMP-13-expression
compared to single growth factor treatment (Figs. 6, 7,
III). Densitometric analysis of the above shown results
(Figs. 6, 7) demonstrated that COX-2- and MMP-13-
expression decreased in growth factor-treated cells
compared to IL-1ß-treated chondrocytes. Combination
of the two growth factors had the strongest inhibitory
effect on the expression of the above mentioned proteins.
Synthesis of the house-keeping protein ß-actin remained
unaffected (Figs. 6, 7).
Redifferentiation of dedifferentiated emigrated
chondrocytes in high-density culture by growth factors
After seven days in high-density cultures,
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Fig. 6. IL-1ß-induced up-regulation of COX-2-expression in emigrated
chondrocytes is prevented by growth factors. Monolayer chondrocytes
were stimulated for 24 hours with IL-1ß followed by co-treatment of
either IGF-I, TGF-ß1 or a combination of both for another 48 hours.
Demonstration of IL-1ß-induced up-regulation of COX-2 by western blot
analysis. Co-treatment with growth factors showed inhibition of IL-1ß-
induced up-regulation of the expression of COX-2. The presence of IGF-
I and TGF-ß1 in combination showed an additive effect. Expression of
the house-keeping protein ß-actin remained unaffected.
dedifferentiated cells derived from monolayer cultures
stimulated for 24 hours with IL-1ß followed by co-
treatment of either IGF-I, TGF-ß1 or a combination of
both for another 24 hours, had redifferentiated into
chondrocytes similar to control cultures (Figs. 8A,C-E).
Typically, these cells had a rounded morphology and
contained a well-developed rough endoplasmic
reticulum, a large Golgi apparatus, the usual complement
of mitochondria, small vacuoles and granules. The cells
had formed a matrix, which was closely attached to the
plasma membrane. This cartilaginous matrix consisted
of fine collagen fibrils running singly and irregularly
(Fig. 8A, C-E). Dedifferentiated cells derived from IL-
1ß-treated cultures did not redifferentiate into
chondrocytes when recultivated in high-density cultures
(Fig. 8B). They did not produce cartilage-specific matrix
and underwent apoptosis, the characteristic
morphological features of this process being membrane
blebbing, disintegration of the nucleus, chromatin
condensation along the nuclear envelope and the
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Fig. 7. IL-1ß-induced up-regulation of MMP-13-expression in emigrated
chondrocytes is prevented by growth factors. Monolayer chondrocytes
were stimulated for 24 hours with IL-1ß followed by co-treatment of
either IGF-I, TGF-ß1 or a combination of both for another 48 hours.
Demonstration of IL-1ß-induced up-regulation of MMP-13 by western
blot analysis. Co-treatment with growth factors showed inhibition of IL-
1ß-induced up-regulation of the expression of MMP-13. The presence of
IGF-I and TGF-ß1 in combination showed an additive effect. Expression
of the house-keeping protein ß-actin remained unaffected.
presence of apoptotic bodies (Fig. 8B).
Growth factors enhance the expression of collagen type
II and ß1-integrin during redifferentiation of
dedifferentiated emigrated chondrocytes in high-density
culture
Western blot investigations revealed high
expressions of collagen type II (Fig. 9A) and of ß1-
integrin (Fig. 9B) in cells derived from control cultures
(0, 12, 24 and 48 hours) in contrast to cultures treated
with IL-1ß, which showed no or only low expression of
collagen type II and ß1-integrin (Fig. 9A,B). In the
presence of IGF-I there was a high increase in the
expression of both proteins. Further enhanced expression
could be demonstrated after co-treatment with TGF-ß1
and even stronger expression using the combination of
both growth factors. These results substantiate the
morphological findings described by the electron
microscopic demonstrations. Densitometric analysis of
these results showed that collagen type II- and ß1-
integrin-expression increased in growth factor-treated
chondrocytes compared to IL-1ß-treated chondrocytes
after transfer into high-density culture. Clearly, the
combination of IGF-I and TGF-ß1 showed an additive
effect on the expression of the above-mentioned
proteins. Synthesis of the house-keeping protein ß-actin
remained unaffected (Fig. 9A,B).
Up-regulation of Erk 1/2 and Sox9 in redifferentiated
emigrated chondrocytes by growth factors in high-density
culture
Western blot analysis demonstrated IL-1ß-induced
down-regulation of both MAPK members in contrast to
control cells and co-treatment with growth factors (Fig.
9C,D). In the presence of IGF-I there was increased
expression of Erk 1/2 and Sox9, which was enhanced by
co-treatment with TGF-ß1. The strongest up-regulation
of Erk 1/2 and Sox9 was observed in combination
treatment of IGF-I and TGF-ß1 (Fig. 9C,D).
Densitometric analysis of the above presented results
demonstrated that Erk 1/2- and Sox9-expression
increased in growth factor-treated chondrocytes
compared to IL-1ß-treated chondrocytes after transfer to
high-density culture. A combination of both growth
factors demonstrated an additive effect on the expression
of Erk 1/2 and Sox9. Synthesis of the house-keeping
protein ß-actin remained unaffected (Fig. 9C-D).
IL-1ß-induced apoptosis in emigrated chondrocytes is
blocked by growth factors in high-density culture
As shown in Fig. 9E there was a high increase of
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Fig. 8. Redifferentiation of dedifferentiated
emigrated chondrocytes in high-density culture
by growth factors. After monolayer treatment for
48 hours with IL-1ß 10 ng/ml alone (B), 24 hours
with 10 ng/ml IL-1ß followed by co-treatment of
either IGF-I 100 ng/ml (C) or TGF-ß1 100 ng/ml
(D) or a combination of both (each 10 ng/ml) for
another 24 hours (E), the cells were transferred
into high-density culture for seven days.
Morphology was evaluated by electron
microscopy. Control cultures showed
characteristic cartilage features, including well
developed chondrocytes (c) embedded in huge
amounts of extracellular matrix (m) (A).
Treatment with IL-1ß for 48 hours led to matrix
breakdown and even cell lysis (B). Application of
IGF-I (C), TGF-ß1 (D) or both in combination (E) resulted in marked improvement of chondrocyte phenotype and even in the formation of cartilage
nodules. Very dense formation of extracellular matrix (m) surrounding well developed chondrocytes (c) was observed. x 4000; Bars: 1µm.
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Fig. 9. Growth factors enhance the expression of cartilage-specific proteins and
block caspase-activation during redifferentiation of dedifferentiated emigrated cells
in high-density culture. After monolayer treatment for 48 hours with IL-1ß 10 ng/ml
alone, 24 hours with 10 ng/ml IL-1ß followed by co-treatment of either IGF-I 100
ng/ml or TGF-ß1 100 ng/ml or a combination of both (each 10 ng/ml) for another 24
hours, the cells were transferred into high-density culture for seven days. In
comparison to control cells (0, 12, 24, 48 hours) treatment with IL-1ß led to
markedly decreased expressions of collagen type II and ß1-integrin (A, B).
However, both IGF-I and TGF-ß1 blocked the IL-1ß-induced down-regulation of
collagen type II and ß1-integrin whereas TGF-ß1 seemed to be more effective. The
combination of IGF-I and TGF-ß1 showed additive effects on the above mentioned
proteins (A, B). Strong IL-1ß-induced down-regulation of both Erk 1/2 and Sox9 is
inhibited by co-treatment of IL-1ß and IGF-I or TGF-ß1 or both at various
concentrations (C, D). TGF-ß1 seemed to be more effective then IGF-I, however
the combination of IGF-I and TGF-ß1 showed clearly stronger up-regulation of Erk
1/2 and Sox9 (C, D). Expression of activated caspase-3 is up-regulated after 24
hours treatment with IL-1ß and even further up-regulated after 48 hours in contrast
to control cells (0, 12, 24, 48 hours). Complete down-regulation of activated
caspase-3 using growth factors was observed (E). Expression of the house-keeping
protein ß-actin remained unaffected.
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Fig. 10. Cultivation of primary isolated
chondrocytes and fibroblasts in high-
density culture. Primary isolated
chondrocytes and fibroblasts were
stimulated with IL-1ß (10 ng/ml) alone for
24 hours in monolayer, before co-
treatment with IGF-I or TGF-ß1 (each 100
ng/ml) or both in combination (each 10
ng/ml) or treated only with IL-1ß for an
additional 24 hours. Afterwards the cells
were transferred to high-density culture
for seven days. Morphology was
evaluated by transmission electron
microscopy. Control cultures of primary
chondrocytes showed well developed
cartilage nodules (A). Treatment with IL-
1ß resulted in cell destruction after 48
hours (B). However, after co-treatment of
primary chondrocytes with IGF-I (C) or
TGF-ß1 (D) or both in combination (E)
there were well defined cartilage nodules.
In contrast, in fibroblast high-density
culture there was no difference between
treatment with IL-1ß or growth factors. In
both cases treatment resulted in cell lysis
(F-J). x 4000; Bars: 1µm.
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Fig. 11. Cultivation of primary isolated chondrocytes and
fibroblasts in high-density culture-western blot analysis. Primary
isolated chondrocytes and fibroblasts were stimulated with IL-1ß
(10 ng/ml) alone for 24 hours in monolayer, before co-treatment
with IGF-I or TGF-ß1 (each 100 ng/ml) or both in combination
(each 10 ng/ml) or treated only with IL-1ß for an additional 24
hours. Primary chondrocytes showed strong expression of
collagen type II, proteoglycanes and ß1-integrin in control cells
and cells treated with IGF-I and/or TGF-ß1 (A-C), whereas there
was no expression of these proteins in fibroblasts, as was
revealed by densitometric analysis. Expression of the house-
keeping protein ß-actin remained unaffected (A-C).
activated caspase-3 after treatment with IL-1ß (10
ng/ml) for 24 hours and even higher expression after 48
hours. In the presence of IGF-I or TGF-ß1 or both in
combination there was complete down-regulation of
activated caspase-3. Densitometric analysis of these
results showed increased expression of activated
caspase-3 in IL-ß-treated chondrocytes compared to
control chondrocytes and chondroytes co-treated with
IGF-I and/or TGF-ß1 after transfer to high-density
culture. Synthesis of the house-keeping protein ß-actin
remained unaffected (Fig. 9E).
Cultivation of primary isolated chondrocytes and
fibroblasts in high-density culture
To test the results performed with emigrated cells
from the alginate system, the same investigations were
performed in high-density culture with either primary
chondrocytes as a positive control or with fibroblasts to
demonstrate negative control. As shown in Fig. 10,
control cultures of primary chondrocytes showed well
developed cartilage nodules. The cells appear as viable
chondrocytes exhibiting characteristic morphological
features, and they formed a strong and regular fibrillar
extracellular matrix (Fig. 10A). In contrast, primary
chondrocytes underwent apoptosis when treated with IL-
1ß (10 ng/ml) for 48 hours (Fig. 10B). However,
treatment with growth factors resulted in well developed
cartilage nodules with viable cells and well developed
and organized cell organelles. The cells formed a dense
and regular extracellular matrix construct (Fig. 10C-E).
In opposite, high-density cultures of fibroblasts were
completely destroyed in the presence of IL-1ß (Fig.
10G), as well as after co-treatment with growth factors
(Fig. 10H-J).
Western blot analysis using antibodies against
collagen type II, proteoglycanes and ß1-integrin revealed
strong expression in control and growth factor-treated
primary chondrocytes, but only low expression after
treatment with IL-1ß (Fig. 11A-C). In contrast, the
expression of the above proteins was neither dectable in
growth factor- nor in IL-1ß-treated fibroblasts (Fig. 11A-
C). Densitometric analysis of the above obtained results
confirmed these results. Synthesis of the house-keeping
protein ß-actin remained unaffected (Fig. 11A-C).
Discussion
This is a continuing study of Shakibaei et al. (2006)
that compares the effect of IGF-I, TGF-ß1 or their
combination on human articular chondrocytes in vitro.
The data presented in this study provide convincing
molecular evidence to support the hypothesis that IGF-I
and TGF-ß1 suppress IL-1ß-induced apoptosis and
cartilage degradation by up-regulation of the MAPK and
Sox9-regulated signalling pathway.
We have made the following novel observations: (1)
IL-1ß-induced morphological alterations, swollen
mitochondria, dilated endoplasmic reticulum and
apoptosis were abolished by co-treatment with IGF-I
or/and TGF-ß1. (2) IGF-I or TGF-ß1 inhibited the IL-
1ß-mediated suppression of key extracellular matrix
components, ß1-integrin and integrin signalling proteins.
(3) IGF-I or TGF-ß1 were able to antagonize the IL-1ß-
dependent up-regulation of MMP-13 and COX-2. (4)
Indeed, IGF-I and/or TGF-ß1 stabilize the chondrogenic
potential in monolayer cultures by the Erk1/2 and
MAPK signalling pathway and Sox9-stimulation,
strongly suggesting that these effects are regulated by
the integrin signalling pathway. (5) Interestingly, these
effects were significantly higher in cells treated with
both growth factors than with single treatment. (6)
Furthermore, the redifferentiation capability of
dedifferentiated monolayer chondrocytes in high-density
culture was stimulated by growth factors and this
capacity was clearly higher in the presence of both
growth factors.
Primary isolated chondrocytes cultured in alginate
beads and then emigrated from alginate beads present a
pure chondrocyte population when introduced into
monolayer culture (Schulze-Tanzil et al., 2004;
Shakibaei et al., 2008). Indeed, production of cartilage-
specific markers by emigrated cells could be shown in
the present study and in previous investigations
(Schulze-Tanzil et al., 2002, 2004). Therefore we
selected these emigrated cells as a representative
chondrocyte subset of cells for our study.
Growth factors stabilize the chondrogenic potential in IL-
1ß-treated dedifferentiated chondrocytes in vitro
Exposing chondrocytes to the pro-inflammatory
cytokine IL-1ß in monolayer culture led to phenotypical
dedifferentiation, finally resulting in apoptotic cell death
and even cell lysis after 72 hours. Indeed, a set of
catabolic cytokines, including IL-1ß and TNF-α, are
known to play an essential role in the pathogenesis of
OA (Fernandes et al., 2002). For this reason, strategies
for inhibiting or antagonizing this process need to be
developed, or rather, must be improved. In the
Autologous Chondrocyte Implantation (ACI) technique
it is a major challenge to obtain sufficient quantities of
differentiated chondrocytes to cover cartilage lesions and
at the same time avoid irreversible dedifferentiation of
these cells during the expansion phase in monolayer
culture (Peterson et al., 2002). Recently, several
investigators have reported on the beneficial effects of
various growth factors such as FGF-2, IGF-I or TGF-ß
on chondrocyte differentiation or redifferentiation in
culture (Martin et al., 1999; Jakob et al., 2001; Mandl et
al., 2002; Barbero et al., 2003; Darling and Athanasiou,
2005). Indeed, we can demonstrate in this study the
positive effects of IGF-I and/or TGF-ß1 on the
maintenance of the chondrogenic potential in
chondrocytes in vitro.
We found that IGF-I, similarly to TGF-ß1,
stimulates the chondrogenic potential of IL-1ß-treated
dedifferentiated chondrocytes, stabilizing the
chondrocyte phenotype and stimulating proliferation,
collagen type II- and ß1-integrin-expression. Stimulation
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of the signalling pathway by integrins leads to activation
of the Ras-MAPkinase signalling pathway in
chondrocytes. We also found that IL-1ß-induced down-
regulation of the MAPKinase members Erk 1/2 and the
master chondrogenic transcription factor Sox9 were
inhibited by IGF-I or TGF-ß1. Moreover, the
combination of IGF-I and TGF-ß1 showed an additive
effect on the expression of the above mentioned proteins.
Cell-cell contact and cell-matrix interactions are
essential and stimulate chondrocyte differentiation and
survival (Yang et al., 1997; Shakibaei et al., 2001). ß1-
integrins as adhesion and signalling molecules play an
important role in cell-matrix interactions in tissues, and
inhibition of such interactions by antibodies in high-
density cultures leads to irreversible dedifferentiation
and apoptosis of chondrocytes (Shakibaei, 1998).
Furthermore, the IGF-I-receptor has been shown before
in our laboratories to cooperate with ß1-integrins in
chondrocytes and this interaction induces the MAPK
pathway (Shakibaei et al., 1999), an important signalling
cascade for chondrocyte differentiation and survival.
Indeed, several investigators have already shown that the
activation of key signalling proteins of the MAPK
pathway increases Sox9 in chondrocytes and this process
is improved by different growth factors (Schulze-Tanzil
et al., 2004; Shakibaei et al., 2006). Moreover, blockade
of the MAPK signal transduction pathway leads to
chondrocyte apoptosis and inhibits the expression of
Sox9 (Murakami et al., 2000; Shakibaei et al., 2001;
Schulze-Tanzil et al., 2004). Sox9 is well known as the
chondrogenic transcription factor for chondrocyte
differentiation and expression of chondrocyte-specific
anabolic genes, such as type II collagen and aggrecan
(de Crombrugghe et al., 2000; Kulyk et al., 2000).
However, cartilage cells from OA express lower
amounts of Sox9 compared to healthy cartilage cells
(Aigner et al., 2003). This might be one explanation of
how growth factor (IGF-I and TGF-ß1) treatment
stabilizes the chondrogenic potential and chondrocyte
survival via integrin/MAPK signalling in this system. 
The detailed mechanism of the growth factor,
influence has not been fully elucidated but several
explanations for these positive effects can be discussed.
Growth factors might increase the number of the
metabolically stimulated cells (Loeser et al., 2003); a
single growth factor might activate and trigger the
signalling pathway in chondrocytes and a combination
of growth factors may activate pathways that are not
affected by a single growth factor and where a
synergistic effect on cell differentiation and survival
could be found (Yaeger et al., 1997; Tsukazaki et al.,
1994; Im et al., 2003).
IGF-I and TGF-ß1 block the up-regulation of the pro-
inflammatory enzymes COX-2 and MMP-13 in
chondrocyte monolayer cultures
Moreover, we also found that IL-1ß-induced
apoptosis and expression of pro-inflammatory enzymes
and mediators, like COX-2 and MMP-13, were inhibited
by IGF-I and/or TGF-ß1. Furthermore, we observed that
the combined treatment of IGF-I and TGF-ß1 had a
stronger inhibitory effect on the expression of COX-2
and MMP-13 than each growth factor separately. Indeed,
cytokines are potent stimulators for the de novo synthesis
of catabolic enzymes such as MMPs, which in cartilage
are responsible for excessive cartilage matrix
degradation in Osteoarthritis (Robbins et al., 2000; Mort
and Billington, 2001; Fernandes et al., 2002; Largo et
al., 2003). Moreover, it has been reported and
demonstrated that cytokines induced the MMP-13 gene
during OA, and that the inhibition of this signalling was
beneficial for reducing cartilage degradation in arthritis
(Liacini et al., 2003). In healthy cartilage, there exists a
balance between MMP-activity and their inhibitors, the
tissue inhibitors of MMPs (known as TIMPs), and this is
precisely regulated. However, in OA this fine balance
between synthesis and degradation is disrupted, resulting
in an increased activity of MMPs and therefore
excessive extracellular matrix degradation and cartilage
destruction (Gowen et al., 1984). Furthermore, other
pro-inflammatory mediators were inhibited by growth
factor treatment such as COX-2, which leads to
prostaglandin E2 (PGE2)-production and pain (Sakai et
al., 2001; Largo et al., 2003). COX-2 is an important
mediator of inflammation and induces joint damage in
OA and other osteoarticular disorders (Gowen et al.,
1984). Moreover, COX-2-synthesis is induced by the
cytokines IL-1ß and TNF-α (Sakai et al., 2001; Largo et
al., 2003). We were able to demonstrate in this study that
IGF-I or TGF-ß1 could inhibit IL-1ß-stimulated
synthesis of COX-2. The inhibitory effect was more
abundant in the combination treatment of both growth
factors.
Growth factors inhibit IL-1ß-induced dedifferentiation and
cell death in high-density cultures
Finally, to test whether the cells from monolayer
cultures redifferentiate into chondrocytes, the emigrated
cells treated with or without growth factors were
transferred to high-density cultures. We found that the
IL-1ß-treated emigrated cells from monolayer cultures
co-treated with growth factors redifferentiated into
chondrocytes after transfer to high-density culture,
produced cartilage-specific matrix, i.e. collagen type II,
integrin adhesion and signalling molecules, activated the
MAPK pathway and the chondrogenic transcription
factor Sox9. Furthermore, the expression of the pro-
apoptotic marker (activated caspase-3) was inhibited in
with IL-1ß and growth factors co-treated emigrated cells.
We further found that the combined treatment with IGF-I
and TGF-ß1 had a stronger inhibitory effect on caspase-
3 expression than each growth factor separately.
To confirm the redifferentiation capacity of
emigrated cells from alginate beads to cartilage
development in high-density cultures, we performed the
same experiments with primary isolated chondrocytes
(positive control) and fibroblasts (negative control).
Fibroblast cells, as opposed to primary chondrocytes and
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emigrated chondrocytes from alginate, were not able to
survive in high-density cultures. These cells underwent
cell death and did not produce any cartilage-specific
markers in the presence or absence of growth factors.
It has been reported that growth factors such as
FGF-2 and TGF-ß can promote (re)differentiation of
dedifferentiated chondrocytes in high-density cultures
(Martin et al., 1999; Barbero et al., 2003) and increase
the expression of Sox9 (Enomoto-Iwamoto et al., 1998;
Zehentner et al., 1999). Furthermore, expression and
activation of the Sox9 gene is inhibited by cytokines like
IL-1ß and TNF-α, and this process seems to be blocked
through growth factors mediated by the MAPK pathway
(de Crombrugghe et al., 2000; Murakami et al., 2000).
In conclusion, the results in this study suggest that
the growth factors (IGF-1 and TGF-ß1), particularly in
combination, markedly suppressed cytokine-induced
pro-inflammatory degrading enzymes and mediators and
enhanced the MAPK signalling pathway and expression
of the master chondrogenic transcription factor Sox9,
thereby stabilizing chondrocyte differentiation. These
intriguing in vitro effects of combined growth factors are
important observations, potentially adding them to the
expanding list of chondroprotective agents thay may find
clinical application next to other anti-rheumatoid, anti-
inflammatory drugs, tissue engineering and ACI.
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